ATE114973T1 - Hepatocyt-stimulierender faktor. - Google Patents

Hepatocyt-stimulierender faktor.

Info

Publication number
ATE114973T1
ATE114973T1 AT88306654T AT88306654T ATE114973T1 AT E114973 T1 ATE114973 T1 AT E114973T1 AT 88306654 T AT88306654 T AT 88306654T AT 88306654 T AT88306654 T AT 88306654T AT E114973 T1 ATE114973 T1 AT E114973T1
Authority
AT
Austria
Prior art keywords
stimulating factor
hepatocyte stimulating
hepatocyte
hepatocytes
stimulating
Prior art date
Application number
AT88306654T
Other languages
English (en)
Inventor
Jack Gauldie
Carl Richards
Peter Michael Lansdorp
Original Assignee
Univ Mcmaster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcmaster filed Critical Univ Mcmaster
Application granted granted Critical
Publication of ATE114973T1 publication Critical patent/ATE114973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT88306654T 1987-07-20 1988-07-20 Hepatocyt-stimulierender faktor. ATE114973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/075,809 US4973478A (en) 1987-07-20 1987-07-20 Treating inflammation with hepatocyte stimulating factor interferon β2

Publications (1)

Publication Number Publication Date
ATE114973T1 true ATE114973T1 (de) 1994-12-15

Family

ID=22128118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88306654T ATE114973T1 (de) 1987-07-20 1988-07-20 Hepatocyt-stimulierender faktor.

Country Status (5)

Country Link
US (1) US4973478A (de)
EP (1) EP0317050B1 (de)
JP (1) JPH01110633A (de)
AT (1) ATE114973T1 (de)
DE (1) DE3852377D1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300292A (en) * 1991-05-03 1994-04-05 The Regents Of The University Of California Composition and method for treating inflammation
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
US5744442A (en) * 1992-08-26 1998-04-28 Bristol Meyers Squibb Company Regulation of cellular invasiveness
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US6410708B1 (en) 1997-11-21 2002-06-25 Genentech, Inc. Nucleic acids encoding A-33 related antigen polypeptides
ATE410512T1 (de) * 1997-11-21 2008-10-15 Genentech Inc Plättchen-spezifische antigene und deren pharmazeutische verwendung
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7273726B2 (en) 1997-11-21 2007-09-25 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
US7282565B2 (en) 1998-03-20 2007-10-16 Genentech, Inc. PRO362 polypeptides
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
SG190596A1 (en) 2008-05-06 2013-06-28 Genentech Inc Affinity matured crig variants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
JPS59172496A (ja) * 1983-03-18 1984-09-29 Kyowa Hakko Kogyo Co Ltd モノクロ−ナル抗体
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
EP0645452A1 (de) * 1985-10-14 1995-03-29 Yeda Research And Development Co. Ltd. Menschliche Interferon-beta 2A und Interferon-beta 2B, Vektoren die ihre kodierende Gene enthalten, Zellinie die diese Interferon produzieren und Verwendung davon in einem Medikament

Also Published As

Publication number Publication date
EP0317050A3 (en) 1990-03-14
JPH01110633A (ja) 1989-04-27
EP0317050B1 (de) 1994-12-07
EP0317050A2 (de) 1989-05-24
US4973478A (en) 1990-11-27
DE3852377D1 (de) 1995-01-19

Similar Documents

Publication Publication Date Title
IT1194043B (it) Produzione dell'ormone bovino della crescita mediante microorganismi
FI893920L (fi) Menetelmä terapeuttisen koostumuksen valmistamiseksi psoriasista vastaan
FR2309663A1 (fr) Procede d'ignifugeage d'articles d'ameublement
DE3852377D1 (de) Hepatocyt-stimulierender Faktor.
FI893530A7 (fi) Fibroblasti-kasvutekijän analogeja
JPS54111618A (en) Dc power supply
IT7950071A0 (it) Perfezionamento nelle carrozze ferroviarie a struttura modulare
DK0401896T3 (da) Carboplatinmateriale
IT8667210A0 (it) Pittura per strutture esposte all'atmosfera
SE415035B (sv) Framstellning av urokinas ur en kultur av levande njurceller odlade i nervaro av glycin
DK426883A (da) Phenoxyalkansyrer med plantevaekstregulerende virkning
ZA857721B (en) Process for treatment of rheumatic diseases
IT8420610A1 (it) "Procedimento per migliorare la crescita delle piante mediante illuminazione intermittente"
IT1111711B (it) Dispositivo per l'alimentazione di una miscela da sinterizzazione
IT8967436A0 (it) Dispositivo per macchina per cucireper il trasporto di pezze da lavorare
IT7948705A0 (it) Dispositivo di fissaggio per rotaie
IE791378L (en) Alpha-difluoromethyl amino acids
BG40653A3 (en) Method for preparing amidothiocarbamate derivatives of carbon acid
FI896031A7 (fi) Kasvinkäsittelykoostumus
IT1099222B (it) Armatura componibile per cavita' di luci in edifici
GB2093613B (en) Dc power supply
DE3675631D1 (de) In-vitro-kulturverfahren.
GB2035724B (en) Interrupted dc supply
GB8717091D0 (en) Air supply to air bath
JPS5579636A (en) Dc power supply

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties